Latest news

Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.

Please direct any media inquiries to: communications@curiumpharma.com

11th June 2026

Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

19th November 2024

Curium Completes Enrollment Early of Phase 3 SOLAR-RECUR Prostate Cancer Trial

13th November 2024

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

Curium - life forward

23rd April 2024

Curium Enrolls First Prostate Cancer Patients in its Phase 3 SOLAR Trials

6th February 2024

Curium Announces Ioflupane I 123 Injection Availability for Friday Patient Use

Curium - life forward

21st November 2023

Curium Completes Patient Enrollment of Phase 3 ECLIPSE Trial Ahead of Schedule